Aberrant Brain Activity at Early Delay Stage Post-radiotherapy as a Biomarker for Predicting Neurocognitive Dysfunction Late-Delayed in Patients With Nasopharyngeal Carcinoma

Background: Increasing evidence indicates that early radiation-induced subtle cerebral changes may be the precursors to permanent brain dysfunction at the late-delayed (LDS) post-radiotherapy (RT) stage. In this study, we aim to track the RT-related longitudinal brain activity in nasopharyngeal carc...

Full description

Bibliographic Details
Main Authors: Yadi Yang, Xiaoshan Lin, Jing Li, Lujun Han, Zhipeng Li, Shiliang Liu, Gangqiang Hou, Chuanmiao Xie, Xiaofei Lv, Yingwei Qiu
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-07-01
Series:Frontiers in Neurology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fneur.2019.00752/full
id doaj-13e4470899aa4bb2b3ec2eebe49d983d
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Yadi Yang
Xiaoshan Lin
Jing Li
Lujun Han
Zhipeng Li
Shiliang Liu
Gangqiang Hou
Chuanmiao Xie
Xiaofei Lv
Yingwei Qiu
spellingShingle Yadi Yang
Xiaoshan Lin
Jing Li
Lujun Han
Zhipeng Li
Shiliang Liu
Gangqiang Hou
Chuanmiao Xie
Xiaofei Lv
Yingwei Qiu
Aberrant Brain Activity at Early Delay Stage Post-radiotherapy as a Biomarker for Predicting Neurocognitive Dysfunction Late-Delayed in Patients With Nasopharyngeal Carcinoma
Frontiers in Neurology
radiotherapy
radiation-induced injury
regional homogeneity
resting-state fMRI
nasopharyngeal carcinoma
neurocognitive dysfunction
author_facet Yadi Yang
Xiaoshan Lin
Jing Li
Lujun Han
Zhipeng Li
Shiliang Liu
Gangqiang Hou
Chuanmiao Xie
Xiaofei Lv
Yingwei Qiu
author_sort Yadi Yang
title Aberrant Brain Activity at Early Delay Stage Post-radiotherapy as a Biomarker for Predicting Neurocognitive Dysfunction Late-Delayed in Patients With Nasopharyngeal Carcinoma
title_short Aberrant Brain Activity at Early Delay Stage Post-radiotherapy as a Biomarker for Predicting Neurocognitive Dysfunction Late-Delayed in Patients With Nasopharyngeal Carcinoma
title_full Aberrant Brain Activity at Early Delay Stage Post-radiotherapy as a Biomarker for Predicting Neurocognitive Dysfunction Late-Delayed in Patients With Nasopharyngeal Carcinoma
title_fullStr Aberrant Brain Activity at Early Delay Stage Post-radiotherapy as a Biomarker for Predicting Neurocognitive Dysfunction Late-Delayed in Patients With Nasopharyngeal Carcinoma
title_full_unstemmed Aberrant Brain Activity at Early Delay Stage Post-radiotherapy as a Biomarker for Predicting Neurocognitive Dysfunction Late-Delayed in Patients With Nasopharyngeal Carcinoma
title_sort aberrant brain activity at early delay stage post-radiotherapy as a biomarker for predicting neurocognitive dysfunction late-delayed in patients with nasopharyngeal carcinoma
publisher Frontiers Media S.A.
series Frontiers in Neurology
issn 1664-2295
publishDate 2019-07-01
description Background: Increasing evidence indicates that early radiation-induced subtle cerebral changes may be the precursors to permanent brain dysfunction at the late-delayed (LDS) post-radiotherapy (RT) stage. In this study, we aim to track the RT-related longitudinal brain activity in nasopharyngeal carcinoma (NPC) patients and to determine whether early abnormal brain activity can predict late neurocognitive dysfunction after RT.Methods: Thirty-three NPC patients were finally included and longitudinally followed up at the following time points: prior to treatment initiation, early-delayed stage (EDS, 1–3 months), and LDS (six months) after RT. Fifteen comparable healthy controls (HCs) were finally included and followed up in parallel. Montreal Cognitive Assessment (MoCA) was used to assess the general cognitive function. Brain activity was recorded via resting-state fMRI and regional homogeneity (ReHo). A whole-brain voxel-wise-based one-way repeated-measure analysis of variance (ANOVA) was conducted to evaluate the longitudinal ReHo changes among the three time points for NPC patients and HCs, respectively. Results were reported at the significant level of a threshold of two-tailed voxel-wise P < 0.01 and cluster level P < 0.05 with Gaussian Random Field (GRF) correction. Finally, the efficacies of the aberrant ReHo at EDS for predicting the cognitive impairment at LDS in NPC patients were evaluated.Results: Significant differences were detected in ReHo among the three time points in NPC patients but not in HCs. Aberrant ReHo was distributed in the bilateral cerebellum, the right temporal lobe, and the left insular areas, which showed different dynamic changes patterns over time. Logistic regression model combining the mean ReHo, age, and irradiation dose on the bilateral temporal lobe had the highest diagnostic efficiency according to the area under the curve (AUC) score (AUC = 0.752, P = 0.023).Conclusions: The post-RT brain activity revealed by ReHo in NPC patients was dynamic, complex, and multifactorial. Furthermore, the combination of the aberrant ReHo at EDS, age, and irradiation dose may serve as a potential biomarker of the RT-induced cognitive impairments at LDS.
topic radiotherapy
radiation-induced injury
regional homogeneity
resting-state fMRI
nasopharyngeal carcinoma
neurocognitive dysfunction
url https://www.frontiersin.org/article/10.3389/fneur.2019.00752/full
work_keys_str_mv AT yadiyang aberrantbrainactivityatearlydelaystagepostradiotherapyasabiomarkerforpredictingneurocognitivedysfunctionlatedelayedinpatientswithnasopharyngealcarcinoma
AT xiaoshanlin aberrantbrainactivityatearlydelaystagepostradiotherapyasabiomarkerforpredictingneurocognitivedysfunctionlatedelayedinpatientswithnasopharyngealcarcinoma
AT jingli aberrantbrainactivityatearlydelaystagepostradiotherapyasabiomarkerforpredictingneurocognitivedysfunctionlatedelayedinpatientswithnasopharyngealcarcinoma
AT lujunhan aberrantbrainactivityatearlydelaystagepostradiotherapyasabiomarkerforpredictingneurocognitivedysfunctionlatedelayedinpatientswithnasopharyngealcarcinoma
AT zhipengli aberrantbrainactivityatearlydelaystagepostradiotherapyasabiomarkerforpredictingneurocognitivedysfunctionlatedelayedinpatientswithnasopharyngealcarcinoma
AT shiliangliu aberrantbrainactivityatearlydelaystagepostradiotherapyasabiomarkerforpredictingneurocognitivedysfunctionlatedelayedinpatientswithnasopharyngealcarcinoma
AT gangqianghou aberrantbrainactivityatearlydelaystagepostradiotherapyasabiomarkerforpredictingneurocognitivedysfunctionlatedelayedinpatientswithnasopharyngealcarcinoma
AT chuanmiaoxie aberrantbrainactivityatearlydelaystagepostradiotherapyasabiomarkerforpredictingneurocognitivedysfunctionlatedelayedinpatientswithnasopharyngealcarcinoma
AT xiaofeilv aberrantbrainactivityatearlydelaystagepostradiotherapyasabiomarkerforpredictingneurocognitivedysfunctionlatedelayedinpatientswithnasopharyngealcarcinoma
AT yingweiqiu aberrantbrainactivityatearlydelaystagepostradiotherapyasabiomarkerforpredictingneurocognitivedysfunctionlatedelayedinpatientswithnasopharyngealcarcinoma
_version_ 1725154505572483072
spelling doaj-13e4470899aa4bb2b3ec2eebe49d983d2020-11-25T01:15:04ZengFrontiers Media S.A.Frontiers in Neurology1664-22952019-07-011010.3389/fneur.2019.00752463107Aberrant Brain Activity at Early Delay Stage Post-radiotherapy as a Biomarker for Predicting Neurocognitive Dysfunction Late-Delayed in Patients With Nasopharyngeal CarcinomaYadi Yang0Xiaoshan Lin1Jing Li2Lujun Han3Zhipeng Li4Shiliang Liu5Gangqiang Hou6Chuanmiao Xie7Xiaofei Lv8Yingwei Qiu9Department of Medical Imaging, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, ChinaDepartment of Radiology, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, ChinaDepartment of Medical Imaging, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, ChinaDepartment of Medical Imaging, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, ChinaDepartment of Medical Imaging, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, ChinaDepartment of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, ChinaShenzhen Kangning Hospital, Shenzhen Mental Health Center, Shenzhen, ChinaDepartment of Medical Imaging, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, ChinaDepartment of Medical Imaging, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, ChinaDepartment of Radiology, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, ChinaBackground: Increasing evidence indicates that early radiation-induced subtle cerebral changes may be the precursors to permanent brain dysfunction at the late-delayed (LDS) post-radiotherapy (RT) stage. In this study, we aim to track the RT-related longitudinal brain activity in nasopharyngeal carcinoma (NPC) patients and to determine whether early abnormal brain activity can predict late neurocognitive dysfunction after RT.Methods: Thirty-three NPC patients were finally included and longitudinally followed up at the following time points: prior to treatment initiation, early-delayed stage (EDS, 1–3 months), and LDS (six months) after RT. Fifteen comparable healthy controls (HCs) were finally included and followed up in parallel. Montreal Cognitive Assessment (MoCA) was used to assess the general cognitive function. Brain activity was recorded via resting-state fMRI and regional homogeneity (ReHo). A whole-brain voxel-wise-based one-way repeated-measure analysis of variance (ANOVA) was conducted to evaluate the longitudinal ReHo changes among the three time points for NPC patients and HCs, respectively. Results were reported at the significant level of a threshold of two-tailed voxel-wise P < 0.01 and cluster level P < 0.05 with Gaussian Random Field (GRF) correction. Finally, the efficacies of the aberrant ReHo at EDS for predicting the cognitive impairment at LDS in NPC patients were evaluated.Results: Significant differences were detected in ReHo among the three time points in NPC patients but not in HCs. Aberrant ReHo was distributed in the bilateral cerebellum, the right temporal lobe, and the left insular areas, which showed different dynamic changes patterns over time. Logistic regression model combining the mean ReHo, age, and irradiation dose on the bilateral temporal lobe had the highest diagnostic efficiency according to the area under the curve (AUC) score (AUC = 0.752, P = 0.023).Conclusions: The post-RT brain activity revealed by ReHo in NPC patients was dynamic, complex, and multifactorial. Furthermore, the combination of the aberrant ReHo at EDS, age, and irradiation dose may serve as a potential biomarker of the RT-induced cognitive impairments at LDS.https://www.frontiersin.org/article/10.3389/fneur.2019.00752/fullradiotherapyradiation-induced injuryregional homogeneityresting-state fMRInasopharyngeal carcinomaneurocognitive dysfunction